Abstract:Catalytic dehalogenative deuteration and tritiation with D2/T2 gas is a widely employed method for precisely introducing hydrogen isotopes into specific positions within organic molecules. While palladium(0) based heterogeneous catalysts, such as Pd/C, are commonly used for this purpose, challenges related to functional group tolerance and incomplete iso-tope incorporation are often encountered, particularly with respect to aryl bromides and chlorides. These long-standing issues pose a hurdle to achieving optimal results in tracer synthesis. The limited incorporation of isotopes for aryl bro-mides and chlorides presents a significant obstacle to the application of this method in the preparation of high specific activity tritium tracers. Herein, we present a novel palladium catalytic system using Zn(OAc)2 as an additive, which ena-bles homogeneous dehalogenative deuteration and tritiation using D2/T2 gas. Under mild reaction conditions, a wide range of drug-like aryl halides and pseudohalides undergo selective deuteration with complete isotope incorporation. The reaction displays excellent compatibility with diverse functional groups, including multiple bonds, O/N-benzyl, and cy-ano groups, which are frequently problematic in Pd/C reactions. Furthermore, this method was successfully applied to the tritiation of four halogenated pharmaceutically relevant molecules, resulting in predictable high specific activity per halogen atom (26.5-27.7 Ci/mmol). Notably, the developed system allows gram-scale preparation of a deuterium-containing intermediate, a crucial step in synthesizing a deuterium-labeled drug molecule. A reaction pathway involving a key intermediate, Pd(Ar)OAc, was proposed to activate hydrogen gas during dehalogenative deuteration and tritiation. This innovative method has potential to change the practice of dehalogenative deuteration and tritiation in the realm of hydrogen isotope labeling.

Synthesis of deuterium labeled dabigatran etexilate

Synthesis of Deuterium Labelled Diclofenac with Improved Isotopic Enrichment

Synthesis and Analysis of Two Versions of Radioisotope Carbon-14 Labelled Dufulin

Synthesis and analysis of carbon-14 labelled Dufulin with high specific activity

Synthesis of Five Deuterium Substituted 2-pyrimidinyloxy-N-arylbenzylamines with Herbicidal activity

Efficient Synthesis of Ractopamine‐D3 via Epoxide‐Opening Strategy

Direct Multi‐Deuterium Labelling of Pirtobrutinib

Determination of Dabigatran in Dog Plasma by LC-MS/MS and Its Application to a Pharmacokinetic Study of Dabigatran Etexilate Nanosuspension

Deuterated reagents in multicomponent reactions to afford deuterium-labeled products

Designing chemical systems for precision deuteration of medicinal building blocks

Dabigatran etexilate, a novel oral anticoagulant for stroke prevention in patients with atrial fibrillation

Stereodefined Rhodium-Catalysed 1,4-H/D Delivery for Modular Syntheses and Deuterium Integration

Hydrodeuteroalkylation of Unactivated Olefins Using Thianthrenium Salts

Cesium Amide‐Catalyzed Selective Deuteration of Benzylic C‐H Bonds with D2 and Application for Tritiation of Pharmaceuticals

Measurement of dabigatran plasma concentrations by calibrated thrombin clotting time in comparison to LC-MS/MS in human volunteers on dialysis

Hydrolytic Degradation Study of Dabigatran Etexilate Mesylate: Isolation and Structural Elucidation of New Degradants

Dofetilide: tritium labelling by several methods

A new method of development and validation of Methanesulfonic acid ester (Methyl, Ethyl) impurity content in dabigatran etexilate mesylate by GC MS

Directed Aromatic Deuteration and Tritiation of Pharmaceuticals by Heavy Alkali Metal Amide Catalysts

Metallaphotoredox Deuteroalkylation Utilizing Thianthrenium Salts

Homogenous Palladium-Catalyzed Dehalogenative Deuteration and Tritiation of Aryl Halides with D2/T2 Gas